鼻副鼻腔炎検出菌に対する局所療法の効果 : ベストロン^【○!R】, イソジン^【○!R】を用いて The Effectiveness of Nasal Nebulizer Therapy with Cefmenoxime Hydrochloride and Nasal Drops of Povidone Iodine for Acute Rhinosinusitis in Children

この論文にアクセスする

この論文をさがす

著者

抄録

We clinically studied the effectiveness of nasal nebulizer therapy with cefmenoxime hydrochloride (CMX) and nasal drops of povidone iodine for acute rhinosinusitis in children. We evaluated the results using the standard for new antibiotics of the Japanese Society of Chemotherapy. The subjects were 50 children with acute rhinosinusitis. By the standard for total evaluation, consisting of clinical and bacteriological study, the cure rate of the CMX nebulizer group was 68%, that of the group using nasal drops of povidone iodine was 23.1%, and that of the controls was 38.5%. The cure rate with nasal drops of povidone iodine was not higher than that with CMX nebulizer therapy. However, with the nasal drops of povidone iodine, in 2 of 3 cases, PISP (penicillin intermediately resistant <i>S. pneumoniae</i>) disappeared and in 2 of 2 cases, MRSA (methicillin-resistant <i>S. aureus</i>) disappeared. The nasal drops of povidone iodine were found to be effective for drug-resistant organisms such as PISP and MRSA.

収録刊行物

  • 耳鼻咽喉科臨床

    耳鼻咽喉科臨床 97(7), 599-604, 2004-07-01

    耳鼻咽喉科臨床学会

参考文献:  15件中 1-15件 を表示

各種コード

  • NII論文ID(NAID)
    10013295921
  • NII書誌ID(NCID)
    AN00107089
  • 本文言語コード
    JPN
  • 資料種別
    NOT
  • ISSN
    00326313
  • NDL 記事登録ID
    7018070
  • NDL 雑誌分類
    ZS43(科学技術--医学--耳鼻咽喉科学)
  • NDL 請求記号
    Z19-421
  • データ提供元
    CJP書誌  NDL  J-STAGE 
ページトップへ